VIA

VIA education library 

VIA

Health Care Professionals Resources
The video resources below are provided by Vitaflo USA and intended for health care professionals only. To view the video resources, please click on the button below and submit your information then check your inbox for the video password. After viewing designated lectures, a certificate of participation can be requested by clicking below.

Request password:

To access the video resources, please fill in the form below to receive the password for watching our video resources. 

Please note: Due to the nature of content on our GSD videos we require additional confirmation that you are a Healthcare professional. To request the password to access the GSD videos please email VIA@VitafloUSA.com
 

*Video resources are intended for health care professionals only.

CLICK HERE TO REQUEST A CERTIFICATE FOR CEUs

  • Your first name
  • Your last name
  • Your email address
Your mail is sending, please wait.

PAH Deficiency Treatment Protocols: An overview and real life successes and challenges implementing in clinic

We invite you to join our presenter Lauren Dwyer, MBA, MPH, RD, LDN, Metabolic Dietitian University of Illinois at Chicago for an overview of the PAH Deficiency Treatment Protocols and a presentation of two case studies.


Participants of this presentation will be able to:

  • Describe the treatment protocol of PAH deficiency
  • Formulate implications for clinical practice
  • Utilize case studies as a reference for managing patient care

This presentation is preapproved for 0.5 CEU.


Financial support for this presentation was provided by Vitaflo USA. The views expressed herein are those of the presenter. The material herein is accurate as of the date it was presented, and is for educational purposes only and is not intended as a substitute for medical advice. Reproduction or distribution of these materials is prohibited.
© 2016 Vitaflo USA LLC. All rights reserved.


Duration – 33 min


Feeding young children with PKU: dietary treatment vs. developmental needs

We invite you to join our speakers Dr. Anita MacDonald, Consultant Dietitian in Inherited Metabolic Dietetics, Honorary Professor in Dietetics, Birmingham Children’s Hospital and Kathryn Moseley, MS, RD, Metabolic Dietitian and Assistant Professor of Pediatrics, University of Southern California/Keck School of Medicine. Dr. Macdonald provides an overview of weaning and feeding challenges for the young child with PKU. She presents a novel approach to medical food administration used in the UK, the introduction of a concentrated semi-solid medical food around 6 months of age designed to meet both the nutritional and developmental needs of the child. Kathryn Moseley provides practical guidance and strategies on the introduction of solid foods, and presents a case study illustrating establishing a child on a concentrated second stage medical food – PKU Gel.


By viewing this presentation, participants will be able to:

  • Identify factors influencing the weaning process and feeding behavior
  • Identify readiness for introducing solid foods
  • Describe the rationale behind the introduction of a second stage concentrated medical food
  • Understand the systematic approach of introducing a second stage concentrated medical food



Duration – 57 min


An Introduction to Motivational Interviewing

We invite you to join our presenter Kelly Walker Lowry, PhD, Clinical Psychologist, for an overview of Motivational Interviewing, a tool to support behavior change in your patients.


Participants of this presentation will be able to:

  • Define Motivational Interviewing
  • Understand how Motivational Interviewing has been used successfully in the healthcare setting
  • Determine which types of patients may benefit from Motivational Interviewing
  • Incorporate strategies of Motivational Interviewing into clinical practice



Duration – 45 min




Glycogen Storage Disease Videos 

Due to the nature of content on our GSD videos we require additional confirmation that you are a Healthcare professional. To request the password to access the videos in the below section, please email VIA@VitafloUSA.com


Nutritional management of Glycogen Storage Disease

Join our speaker Dr. Laurie Tsilianidis, M.D. of Cleveland Clinic for a presentation on the Nutritional management of Glycogen Storage disease.


By viewing this presentation, participants will be able to:

  • Explain the dietary guidelines and sugar restrictions of hepatic GSD
  • Discuss the physiological basis for nutrition management of each type of GSD discussed
  • Apply the provided information to prevent long-term metabolic derangements and complications while optimizing nutritional status in their GSD patients.



Duration – 55 min


Case study: GSD Type 1b Infant / Glycogen Storage Disease Type 0 Case Study

Case study: GSD Type 1b Infant (segment 1)

Join Joyanna Hansen, PhD, RD, LD, assistant professor of the department of Molecular and Medical Genetics and Metabolic Dietitian from the Oregon Health & Science University as she presents a case study on an infant with GSD Type 1b and the use of continuous glucose monitoring.


By viewing this presentation, participants will be able to:

  • Describe medical nutrition therapy guidelines for GSD infants
  • Formulate implications in managing a GSD type 1b infant
  • Identify potential applications for use of continuous glucose monitoring in GSD patients

This presentation is preapproved for 1 CEU


Duration – 0-27 min


Glycogen Storage Disease Type 0 Case Study (segment 2)

We invite you to join Dr. Laurie Tsilianidis, M.D. of Cleveland Clinic as she presents a case study describing a Glycogen Storage Disease Type 0 diagnosis.


By viewing this presentation, participants will be able to:

  • Recognize symptoms of a possible GSD Type 0 diagnosis
  • Describe initial follow up therapy for GSD type 0
  • Identify the differences between a type 1 diabetes diagnosis and a GSD type 0


Duration – 27-50 min


Nutritional Management of GSD Type I / Nutritional Management of GSD Type III

Nutritional Management of GSD Type I (segment 1)

Please join our speaker Kaitalin Ross, RD, LD/N of The University of Florida Glycogen Storage Disease Program as she explains the Nutritional Management of GSD Type I at University of Florida.


By viewing this presentation, participants will be able to:

  • Identify the different dietary guidelines and /or sugar restrictions associated with Type 1 of GSD discussed
  • Explain the rationale of the current nutritional managements associated with Type 1 of GSD discussed
  • Apply knowledge of nutritional deficiencies to promote appropriate weight gain/growth and optimize the patient’s nutritional status



Duration – 0-27 min


Nutritional Management of GSD Type III (segment 2)

Please join Anne Boney, Med, RD, LD, Pediatric metabolic dietitian as she describes evidence behind the Nutritional Management of GSD Type III


Participants of this presentation will be able to:

  • Identify the differences between GSD Type III a and Type III b
  • Explain the evidence to support nutritional management of GSD type III
  • Apply implications from case examples of nutritional management in practical situations



Duration – 27-58 min


Evidence and Practices in the Use of Uncooked Cornstarch and Glycosade in GSD / Creating a Glycogen Storage Disease Program

Evidence and Practices in the Use of Uncooked Cornstarch and Glycosade in GSD (segment 1)

We invite you to join our speaker Dr. David Weinstein of the University of Florida Glycogen Storage Disease Program, as he describes the use of uncooked cornstarch and Glycosade in treating GSD patients.


By participating in this presentation, participants will be able to:

  • Explain the history of cornstartch use and compare with continuous glucose therapy
  • Describe The University of Florida’s approach to dosing cornstarch
  • Describe new data on the long term outcome in people treated with cornstarch
  • Discuss advances in the cornstarch field (Glycosade)



Duration – 0-38 min


Creating a Glycogen Storage Disease Program (segment 2)

Join our speaker Dr. Laurie Tsilianidis, M.D. as she explains the process of setting up a Glycogen Storage Disease Program at the Cleveland Clinic


Participants of this presentation will:

  • Gain an understanding of how to develop an inpatient protocol for the initiation of Glycosade
  • Develop Practical strategies for patient selection, dosing, monitoring and follow up



Duration – 38-55 min